324 related articles for article (PubMed ID: 17041845)
1. Use of streptogramin growth promoters in poultry and isolation of streptogramin-resistant Enterococcus faecium from humans.
Kieke AL; Borchardt MA; Kieke BA; Spencer SK; Vandermause MF; Smith KE; Jawahir SL; Belongia EA;
J Infect Dis; 2006 Nov; 194(9):1200-8. PubMed ID: 17041845
[TBL] [Abstract][Full Text] [Related]
2. Quinupristin-dalfopristin-resistant Enterococcus faecium on chicken and in human stool specimens.
McDonald LC; Rossiter S; Mackinson C; Wang YY; Johnson S; Sullivan M; Sokolow R; DeBess E; Gilbert L; Benson JA; Hill B; Angulo FJ
N Engl J Med; 2001 Oct; 345(16):1155-60. PubMed ID: 11642231
[TBL] [Abstract][Full Text] [Related]
3. Isolation of streptogramin-resistant Enterococcus faecium from human and non-human sources in a rural community.
Solway S; Vincent L; Tian N; Woodford N; Bendall R
J Antimicrob Chemother; 2003 Oct; 52(4):707-10. PubMed ID: 12951343
[TBL] [Abstract][Full Text] [Related]
4. Intra-hospital dissemination of quinupristin/dalfopristin- and vancomycin-resistant Enterococcus faecium in a paediatric ward of a German hospital.
Werner G; Klare I; Spencker FB; Witte W
J Antimicrob Chemother; 2003 Jul; 52(1):113-5. PubMed ID: 12805253
[TBL] [Abstract][Full Text] [Related]
5. Distribution of streptogramin resistance determinants among Enterococcus faecium from a poultry production environment of the USA.
Hayes JR; Wagner DD; English LL; Carr LE; Joseph SW
J Antimicrob Chemother; 2005 Jan; 55(1):123-6. PubMed ID: 15574480
[TBL] [Abstract][Full Text] [Related]
6. High-frequency recovery of quinupristin-dalfopristin-resistant Enterococcus faecium isolates from the poultry production environment.
Hayes JR; McIntosh AC; Qaiyumi S; Johnson JA; English LL; Carr LE; Wagner DD; Joseph SW
J Clin Microbiol; 2001 Jun; 39(6):2298-9. PubMed ID: 11376075
[TBL] [Abstract][Full Text] [Related]
7. Quinupristin/Dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium.
Winston DJ; Emmanouilides C; Kroeber A; Hindler J; Bruckner DA; Territo MC; Busuttil RW
Clin Infect Dis; 2000 May; 30(5):790-7. PubMed ID: 10817685
[TBL] [Abstract][Full Text] [Related]
8. Quinupristin/dalfopristin-resistant enterococci of the satA (vatD) and satG (vatE) genotypes from different ecological origins in Germany.
Werner G; Klare I; Heier H; Hinz KH; Böhme G; Wendt M; Witte W
Microb Drug Resist; 2000; 6(1):37-47. PubMed ID: 10868806
[TBL] [Abstract][Full Text] [Related]
9. Distribution of streptogramin resistance genes and genetic relatedness among quinupristin/dalfopristin-resistant Enterococcus faecium recovered from pigs and chickens in Korea.
Hwang IY; Ku HO; Lim SK; Lee KJ; Park CK; Jung GS; Jung SC; Park YH; Nam HM
Res Vet Sci; 2010 Aug; 89(1):1-4. PubMed ID: 20206952
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of antimicrobial resistance in enterococci of animal origin.
Hershberger E; Oprea SF; Donabedian SM; Perri M; Bozigar P; Bartlett P; Zervos MJ
J Antimicrob Chemother; 2005 Jan; 55(1):127-30. PubMed ID: 15574473
[TBL] [Abstract][Full Text] [Related]
11. Reduced susceptibility to quinupristin/dalfopristin in Enterococcus faecium in Greece without prior exposure to the agent.
Karanika M; Prati A; Kiritsi M; Spiliopoulou I; Neonakis I; Anifantaki M; Petinaki E
Int J Antimicrob Agents; 2008 Jan; 31(1):55-7. PubMed ID: 17923393
[TBL] [Abstract][Full Text] [Related]
12. Implications of multiple antimicrobial-resistant enterococci associated with the poultry environment.
Joseph SW; Hayes JR; English LL; Carr LE; Wagner DD
Food Addit Contam; 2001 Dec; 18(12):1118-23. PubMed ID: 11761123
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility and macrolide resistance genes in Enterococcus faecium with reduced susceptibility to quinupristin-dalfopristin: level of quinupristin-dalfopristin resistance is not dependent on erm(B) attenuator region sequence.
López F; Culebras E; Betriú C; Rodríguez-Avial I; Gómez M; Picazo JJ
Diagn Microbiol Infect Dis; 2010 Jan; 66(1):73-7. PubMed ID: 18653303
[TBL] [Abstract][Full Text] [Related]
14. Effect of quinupristin/dalfopristin alone or in combination with vancomycin on the structure of Enterococcus faecium.
Lorian V; Fernandes F
Drugs Exp Clin Res; 1998; 24(2):73-6. PubMed ID: 9675547
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of quinupristin/dalfopristin and other antibiotics against ampicillin-resistant enterococcus faecium.
Wang FD; Liu IM; Liu CY
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):119-23. PubMed ID: 10677922
[TBL] [Abstract][Full Text] [Related]
16. Prospective, randomized study comparing quinupristin-dalfopristin with linezolid in the treatment of vancomycin-resistant Enterococcus faecium infections.
Raad I; Hachem R; Hanna H; Afif C; Escalante C; Kantarjian H; Rolston K
J Antimicrob Chemother; 2004 Apr; 53(4):646-9. PubMed ID: 14998986
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of linezolid & quinupristin/dalfopristin against Gram-positive cocci.
Tünger A; Aydemir S; Uluer S; Cilli F
Indian J Med Res; 2004 Dec; 120(6):546-52. PubMed ID: 15654141
[TBL] [Abstract][Full Text] [Related]
18. Quantifying human health risks from virginiamycin used in chickens.
Cox LA; Popken DA
Risk Anal; 2004 Feb; 24(1):271-88. PubMed ID: 15028017
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial resistance and the mechanisms implicated in faecal enterococci from healthy humans, poultry and pets in Portugal.
Poeta P; Costa D; Rodrigues J; Torres C
Int J Antimicrob Agents; 2006 Feb; 27(2):131-7. PubMed ID: 16388931
[TBL] [Abstract][Full Text] [Related]
20. Treatment of vancomycin-resistant Enterococcus faecium infections with an investigational streptogramin antibiotic (quinupristin/dalfopristin): a report of fifteen cases.
Dever LL; Smith SM; Dejesus D; Masurekar M; Patel D; Kaminski ZC; Johanson WG
Microb Drug Resist; 1996; 2(4):407-13. PubMed ID: 9158811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
